Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protara Therapeutics (TARA) Capital Expenditures (2016 - 2025)

Protara Therapeutics' Capital Expenditures history spans 13 years, with the latest figure at $24000.0 for Q4 2025.

  • Quarterly Capital Expenditures changed N/A to $24000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $94000.0 through Dec 2025, up 108.89% year-over-year, with the annual reading at $94000.0 for FY2025, 49.21% up from the prior year.
  • Capital Expenditures came in at $24000.0 for Q4 2025, up from $4000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $326000.0 in Q2 2021 to a low of -$64000.0 in Q3 2021.
  • The 5-year median for Capital Expenditures is $21000.0 (2022), against an average of $53937.5.
  • The largest YoY upside for Capital Expenditures was 5533.33% in 2021 against a maximum downside of 148.48% in 2021.
  • Protara Therapeutics' Capital Expenditures stood at $44000.0 in 2021, then tumbled by 86.36% to $6000.0 in 2022, then surged by 516.67% to $37000.0 in 2023, then plummeted by 78.38% to $8000.0 in 2024, then surged by 200.0% to $24000.0 in 2025.
  • Per Business Quant, the three most recent readings for TARA's Capital Expenditures are $24000.0 (Q4 2025), $4000.0 (Q3 2025), and $22000.0 (Q2 2025).